Kaposi's sarcoma and human chorionic gonadotropin: Mechanisms, moieties and mysteries

Davide Bisacchi, Douglas M. Noonan, Sebastiano Carlone, Adriana Albini, Ulrich Pfeffer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Kaposi's Sarcoma (KS) is a highly angiogenic neoplasm associated with infection by the human γ-herpesvirus, HHV-8 or Kaposi's sarcoma herpes virus (KSHV). When in 1872 the Hungarian scientist Moritz Kaposi described the sarcoma, which was later named after him, he was dealing with a rare dermatologic disease. Today, KS is a more common pathology due to its high incidence in AIDS, in immuno-suppressed transplantation patients and, in its endemic form, in Africa. The introduction of highly active anti-retroviral therapy (HAART) has led to a drastic reduction of KS incidence in HIV-infected patients, but in some cases KS resists the treatment. KS is more common in men than in women. The observation of spontaneous remissions during pregnancy stimulated investigations into the potential anti-KS activity of the pregnancy hormone human chorionic gonadotropin (hCG). The variable effect in clinical trials using urinary preparations of the hormone (u-hCG) has led to the hypothesis that contaminating moieties present in these preparations may account for the anti-KS effect observed in vitro. While the discrepancy between laboratory tests and clinical trials remains a mystery, little is known about potential anti-KS mechanisms of the hormone itself and/or other active moieties present in u-hCG.

Original languageEnglish
Pages (from-to)1315-1320
Number of pages6
JournalBiological Chemistry
Volume383
Issue number9
DOIs
Publication statusPublished - Sep 1 2002

Fingerprint

Kaposi's Sarcoma
Chorionic Gonadotropin
Hormones
Pathology
Viruses
Human Herpesvirus 8
Clinical Trials
Spontaneous Remission
Pregnancy
Incidence
Rare Diseases
Acquired Immunodeficiency Syndrome
Transplantation
Observation
HIV

Keywords

  • AIDS related tumors
  • Angiogenesis
  • Chorionic gonadotropin
  • Human herpesvirus 8
  • Kaposi's sarcoma

ASJC Scopus subject areas

  • Biochemistry

Cite this

Kaposi's sarcoma and human chorionic gonadotropin : Mechanisms, moieties and mysteries. / Bisacchi, Davide; Noonan, Douglas M.; Carlone, Sebastiano; Albini, Adriana; Pfeffer, Ulrich.

In: Biological Chemistry, Vol. 383, No. 9, 01.09.2002, p. 1315-1320.

Research output: Contribution to journalArticle

@article{ba94add730664203a8abb80bca42b8ba,
title = "Kaposi's sarcoma and human chorionic gonadotropin: Mechanisms, moieties and mysteries",
abstract = "Kaposi's Sarcoma (KS) is a highly angiogenic neoplasm associated with infection by the human γ-herpesvirus, HHV-8 or Kaposi's sarcoma herpes virus (KSHV). When in 1872 the Hungarian scientist Moritz Kaposi described the sarcoma, which was later named after him, he was dealing with a rare dermatologic disease. Today, KS is a more common pathology due to its high incidence in AIDS, in immuno-suppressed transplantation patients and, in its endemic form, in Africa. The introduction of highly active anti-retroviral therapy (HAART) has led to a drastic reduction of KS incidence in HIV-infected patients, but in some cases KS resists the treatment. KS is more common in men than in women. The observation of spontaneous remissions during pregnancy stimulated investigations into the potential anti-KS activity of the pregnancy hormone human chorionic gonadotropin (hCG). The variable effect in clinical trials using urinary preparations of the hormone (u-hCG) has led to the hypothesis that contaminating moieties present in these preparations may account for the anti-KS effect observed in vitro. While the discrepancy between laboratory tests and clinical trials remains a mystery, little is known about potential anti-KS mechanisms of the hormone itself and/or other active moieties present in u-hCG.",
keywords = "AIDS related tumors, Angiogenesis, Chorionic gonadotropin, Human herpesvirus 8, Kaposi's sarcoma",
author = "Davide Bisacchi and Noonan, {Douglas M.} and Sebastiano Carlone and Adriana Albini and Ulrich Pfeffer",
year = "2002",
month = "9",
day = "1",
doi = "10.1515/BC.2002.149",
language = "English",
volume = "383",
pages = "1315--1320",
journal = "Biological Chemistry",
issn = "1431-6730",
publisher = "Walter de Gruyter GmbH",
number = "9",

}

TY - JOUR

T1 - Kaposi's sarcoma and human chorionic gonadotropin

T2 - Mechanisms, moieties and mysteries

AU - Bisacchi, Davide

AU - Noonan, Douglas M.

AU - Carlone, Sebastiano

AU - Albini, Adriana

AU - Pfeffer, Ulrich

PY - 2002/9/1

Y1 - 2002/9/1

N2 - Kaposi's Sarcoma (KS) is a highly angiogenic neoplasm associated with infection by the human γ-herpesvirus, HHV-8 or Kaposi's sarcoma herpes virus (KSHV). When in 1872 the Hungarian scientist Moritz Kaposi described the sarcoma, which was later named after him, he was dealing with a rare dermatologic disease. Today, KS is a more common pathology due to its high incidence in AIDS, in immuno-suppressed transplantation patients and, in its endemic form, in Africa. The introduction of highly active anti-retroviral therapy (HAART) has led to a drastic reduction of KS incidence in HIV-infected patients, but in some cases KS resists the treatment. KS is more common in men than in women. The observation of spontaneous remissions during pregnancy stimulated investigations into the potential anti-KS activity of the pregnancy hormone human chorionic gonadotropin (hCG). The variable effect in clinical trials using urinary preparations of the hormone (u-hCG) has led to the hypothesis that contaminating moieties present in these preparations may account for the anti-KS effect observed in vitro. While the discrepancy between laboratory tests and clinical trials remains a mystery, little is known about potential anti-KS mechanisms of the hormone itself and/or other active moieties present in u-hCG.

AB - Kaposi's Sarcoma (KS) is a highly angiogenic neoplasm associated with infection by the human γ-herpesvirus, HHV-8 or Kaposi's sarcoma herpes virus (KSHV). When in 1872 the Hungarian scientist Moritz Kaposi described the sarcoma, which was later named after him, he was dealing with a rare dermatologic disease. Today, KS is a more common pathology due to its high incidence in AIDS, in immuno-suppressed transplantation patients and, in its endemic form, in Africa. The introduction of highly active anti-retroviral therapy (HAART) has led to a drastic reduction of KS incidence in HIV-infected patients, but in some cases KS resists the treatment. KS is more common in men than in women. The observation of spontaneous remissions during pregnancy stimulated investigations into the potential anti-KS activity of the pregnancy hormone human chorionic gonadotropin (hCG). The variable effect in clinical trials using urinary preparations of the hormone (u-hCG) has led to the hypothesis that contaminating moieties present in these preparations may account for the anti-KS effect observed in vitro. While the discrepancy between laboratory tests and clinical trials remains a mystery, little is known about potential anti-KS mechanisms of the hormone itself and/or other active moieties present in u-hCG.

KW - AIDS related tumors

KW - Angiogenesis

KW - Chorionic gonadotropin

KW - Human herpesvirus 8

KW - Kaposi's sarcoma

UR - http://www.scopus.com/inward/record.url?scp=0036753859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036753859&partnerID=8YFLogxK

U2 - 10.1515/BC.2002.149

DO - 10.1515/BC.2002.149

M3 - Article

C2 - 12437123

AN - SCOPUS:0036753859

VL - 383

SP - 1315

EP - 1320

JO - Biological Chemistry

JF - Biological Chemistry

SN - 1431-6730

IS - 9

ER -